Back to Search Start Over

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.

Details

Language :
English
ISSN :
00283878
Volume :
73
Issue :
24
Database :
Supplemental Index
Journal :
Neurology
Publication Type :
Academic Journal
Accession number :
105272271
Full Text :
https://doi.org/10.1212/WNL.0b013e3181c67808